Synthesis and biological evaluations of novel bendazac lysine analogues as potent anticataract agents.

Bioorg Med Chem Lett

School of Chemistry and Chemical Engineering, Nanjing University, Nanjing 210093, PR China.

Published: April 2010

AI Article Synopsis

  • Novel bendazac analogs and their salts were created, resulting in compounds with high solubility in water (over 100 mg/mL).
  • In vitro tests indicated that many of these compounds effectively protect against oxidative damage.
  • Specifically, compound 13d not only provided protection but also boosted antioxidant levels in a model of oxidative stress, suggesting it may guard the lens through antioxidant mechanisms.

Article Abstract

Novel bendazac analogues and their salts have been designed and prepared. The resulting compounds (13c-d, 15c, 17c) showed very good aqueous solubility (>100 mg/mL). An in vitro assay showed that most of the resulting compounds had potent protective activity against the oxidative damage. Particularly, compound 13d was also able to enhance the WSP and T-AOC level in the H(2)O(2)/FeCl(3)-induced oxidative damage model, indicating the resulting compound may protect the lens through an antioxidant pathway.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmcl.2010.02.061DOI Listing

Publication Analysis

Top Keywords

novel bendazac
8
oxidative damage
8
synthesis biological
4
biological evaluations
4
evaluations novel
4
bendazac lysine
4
lysine analogues
4
analogues potent
4
potent anticataract
4
anticataract agents
4

Similar Publications

Pharmacological treatment of presbyopia: A systematic review.

Eur J Transl Myol

September 2022

Faculty of Science, Engineering and Computing, School of Life Sciences, Pharmacy and Chemistry, Department of Pharmacy, Kingston University, London.

The aim of this study was to identify the efficacy of drug agents for pharmacological Treatment of Presbyopia. Published research papers were reviewed using the relevant terms in PubMed, Science direct, Google scholar, Medline, Google patent, Ovid, Cochrane Database of Systematic Reviews, Scopus. In the initial search, 2270 records were obtained.

View Article and Find Full Text PDF

Tumor growth and metastasis are caused by many factors. The complexity means that a multi-target combination therapy strategy should be selected against tumor growth and metastasis. Here, cisplatin (CDDP) and bendazac (Ben) were designed as a novel NSAID-Pt(IV) nanoplatform, which is an effective weapon for combating tumor growth and metastasis.

View Article and Find Full Text PDF
Article Synopsis
  • A new method was developed to identify two impurities in bendazac lysine eye drops using a combination of liquid chromatography and high-resolution mass spectrometry.
  • One impurity was quickly characterized by comparing it to a reference standard, while the other was identified as 2-(1,5-dibenzyl-1H-indazol-3-yloxy)acetic acid through advanced techniques like NMR and preparative HPLC.
  • The study also suggested a possible mechanism behind how these impurities formed during the manufacturing process.
View Article and Find Full Text PDF
Article Synopsis
  • Novel bendazac analogs and their salts were created, resulting in compounds with high solubility in water (over 100 mg/mL).
  • In vitro tests indicated that many of these compounds effectively protect against oxidative damage.
  • Specifically, compound 13d not only provided protection but also boosted antioxidant levels in a model of oxidative stress, suggesting it may guard the lens through antioxidant mechanisms.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!